American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Top Cited Papers
- 1 January 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (1) , 127-145
- https://doi.org/10.1200/jco.2008.17.2627
Abstract
Purpose To update a clinical practice guideline on the use of chemotherapy and radiation therapy protectants for patients with cancer. Methods An update committee reviewed literature published sinc...Keywords
This publication has 47 references indexed in Scilit:
- Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457—A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2006
- Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01Journal of Clinical Oncology, 2005
- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2004
- Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trialInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignanciesGynecologic Oncology, 2003
- Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsAnnals of Oncology, 2003
- Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized StudyMedical Oncology, 2003
- Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 2002